Malignant Pleural Effusion
72
8
9
28
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
11 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
6 terminated out of 72 trials
82.4%
-4.2% vs benchmark
8%
6 trials in Phase 3/4
39%
11 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 28 completed trials
Clinical Trials (72)
Cancer Ratio and Cancer Ratio Plus in Malignant and Tuberculous Pleural Effusions
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter
UNC Pleural Fluid Registry
The Experiences of Patients Living With Malignant Pleural Effusions
Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
Cytological Examination of Malignant Pleural Effusion in Breast Cancer
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Effectiveness of Intercostal Tube Drainage Vs Pigtail Catheter Drainage Vs Ultrasound-Guided Aspiration in Management of Massive Malignant Pleural Effusion
A Study of MT027 in Patients with Pleural Malignant Tumors
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion
Feasibility of Ambulatory Talc. Pleurodesis
OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.